Thomsen K, Molin L, Volden G, Lange Wantzin G, Hellbe L
Acta Derm Venereol. 1984;64(6):563-6.
Twenty patients with mycosis fungoides and four with Sézary's syndrome were treated with 13-cis-retinoic acid as single therapy in an initial dose of 1 to 2 mg per kg body weight in most cases. Complete remission in mycosis fungoides was obtained in six cases (33%) and partial remission in another ten cases (50%). No convincing response was observed in three cases, and progression of limited nodular lesions occurred in one case. In cases responding to treatment the first sign of remission was observed within two to four weeks. Our short-term experience is that the drug is effective in early as well as advanced stages of mycosis fungoides. Patients with Sézary's syndrome, however, did not respond to the same extent.
20例蕈样肉芽肿患者和4例塞扎里综合征患者接受了13-顺式维甲酸单药治疗,多数情况下初始剂量为每公斤体重1至2毫克。蕈样肉芽肿患者中6例(33%)获得完全缓解,另外10例(50%)获得部分缓解。3例未观察到明显反应,1例局限性结节性病变进展。在对治疗有反应的病例中,在两到四周内观察到缓解的第一个迹象。我们的短期经验是,该药物在蕈样肉芽肿的早期和晚期均有效。然而,塞扎里综合征患者的反应程度不同。